Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

• Egile Nagusiak: Yadan Liu (Egilea), Bin Liang (Egilea), Yan Liu (Egilea), Guoqing Wei (Egilea), Wenjun Wu (Egilea), Luxin Yang (Egilea), Li Yang (Egilea), He Huang (Egilea), Jue Xie (Egilea), Yongxian Hu (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Chimeric antigen receptor T cell (CAR-T) therapy is successful in improving treatment outcomes for relapsed/refractory acute lymphoblastic leukemia (R/R ALL). However, toxicities associated with CAR-T therapy are being increasingly identified. Pancytopenia is one of the most common compl...